We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YALA:NYSEYalla Group Limited Analysis

Data as of 2026-09-01 - not real-time

$5.49

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Yalla Group Limited is neutral at $5.49, with no clear ordering between short and long averages. Over a rolling month the price has gained 1.1%. With RSI at 50.0 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at $5.19 and resistance at $5.74.
Valuation screens as undervalued: a P/E of 7.2 sits below the sector average of 35.3. Analyst price targets sit 39.9% above the current price. Revenue is contracting at 2.3% on a 40.8% profit margin.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 26.7%, a beta of 0.85 and a maximum drawdown of 35.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 4/10 conviction over the longer horizon.

Top Market Events

DUBAI, 18th August, 2026 WAM -- Yalla Group Limited announced today its financial results for the second quarter of...Yalla Group Ltd YALA reports strong Q2 2026 results with revenue of USD82.Yahoo Finance14dYalla Group Limited YALA Q2 FY2026 earnings call transcriptYalla delivered Q2 2026 revenue of $82.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 6.37
  • MACD momentum is negative
  • Maximum drawdown of 35.8%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 7.2 versus sector average of 35.3
  • Trading below the 200-day average of 6.37
  • Analyst targets imply +39.9% versus the current price

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 7.2 versus sector average of 35.3
  • Analyst targets imply +39.9% versus the current price
  • Profit margin of 40.8% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth-2.30%
Profit Margin40.78%
P/E Ratio7.2
ROE16.82%
ROA7.30%
Debt/Equity0.53
P/B Ratio1.0
Industry P/E35.3

Technical Analysis

TrendNeutral
RSI50.0
Support$5.19
Resistance$5.74
MA 20$5.49
MA 50$5.43
MA 200$6.37
MACDBearish
VolumeStable
Fear & Greed Index93.09

Valuation

Target Price$7.68
Upside/Downside39.89%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.85
Volatility26.75%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.